TABLE 2.

Adjusted Odds of Treatment Persistence and Adherence According to Demographic Characteristics and Comorbidities

Characteristic	Persistence from months 1 to 12		Adherence from months 1 to 12
	Odds ratio	95% CI	Odds ratio	95% CI
Age younger than 30 years	Reference
31-40 years	1.22	0.51-2.93	0.84	0.34-2.06
41-50 years	0.82	0.34-1.95	0.57	0.24-1.39
51-60 years	0.88	0.36-2.18	0.55	0.22-1.40
>60 years	1.24	0.46-3.35	0.76	0.28-2.10
Male sex	Reference
Female sex	0.32	0.14-0.75	0.33	0.14-0.77
Race
White or Caucasian	Reference
Black or African American	1.10	0.70-1.74	1.19	0.76-1.89
Othera	0.88	0.36-2.18	0.95	0.39-2.35
Ethnicity
Not Hispanic or Latino	Reference
Hispanic or Latino	2.88	0.95-8.71	2.76	0.92-8.29
Comorbidities
HTN (present vs absent)	1.23	0.77-1.95	1.06	0.67-1.67
HLD (present vs absent)	0.83	0.53-1.29	1.04	0.67-1.61
T2DM (present vs absent)	0.78	0.41-1.47	0.83	0.44-1.56
CVD (present vs absent)	0.79	0.41-1.53	0.98	0.50-1.89
MDD (present vs absent)	0.79	0.51-1.2	0.81	0.53-1.25

^a Asian, American Indian or Alaskan Native, and all other races specified.

CVD = cardiovascular disease; HLD = hyperlipidemia; HTN = hypertension; MDD = major depressive disorder; T2DM = type 2 diabetes.